Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GRM8 | O00222 | 4/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 3/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8582041 | 0.80 | AKR1C3 (0.67) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL307016 | 0.80 | AKR1C3 (0.67) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL3992888 | 0.80 | AKR1C3 (0.67) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL5861774 | 0.79 | ACP3 (0.58) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL2458450 | 0.78 | HTT (0.53) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL2458448 | 0.78 | HTT (0.53) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL1067934 | 0.78 | ACP3 (0.50) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL742437 | 0.78 | ACP3 (0.56) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL5157317 | 0.78 | ACP3 (0.56) | ACP3TP53HTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL31652701 | 0.78 | ACP3 (0.56) | ACP3TP53HTTL3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | DIC CORPORATION (JP) | 2020-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | PYM1, ZYX, CRY1 | ACP3 3995/4885TP53 4787/4885HTT 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.